Compare PCRX & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | IBCP |
|---|---|---|
| Founded | 2006 | 1864 |
| Country | United States | United States |
| Employees | N/A | 270 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 819.9M |
| IPO Year | 2010 | 2010 |
| Metric | PCRX | IBCP |
|---|---|---|
| Price | $36.40 | $37.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $33.57 | ★ $41.20 |
| AVG Volume (30 Days) | ★ 2.3M | 174.6K |
| Earning Date | 11-13-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | ★ 107.44 | 3.48 |
| EPS | 0.19 | ★ 1.72 |
| Revenue | ★ $541,533,000.00 | $32,075,000.00 |
| Revenue This Year | $3.84 | $14.56 |
| Revenue Next Year | $4.73 | $12.02 |
| P/E Ratio | $191.58 | ★ $21.27 |
| Revenue Growth | ★ 26.04 | 0.30 |
| 52 Week Low | $18.80 | $29.83 |
| 52 Week High | $36.67 | $39.24 |
| Indicator | PCRX | IBCP |
|---|---|---|
| Relative Strength Index (RSI) | 83.12 | 60.61 |
| Support Level | $21.97 | $34.89 |
| Resistance Level | $36.45 | $38.93 |
| Average True Range (ATR) | 0.09 | 0.79 |
| MACD | -0.28 | 0.16 |
| Stochastic Oscillator | 25.35 | 92.81 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Independent Bank Corp. operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers. The firm's principal markets are the rural and suburban communities across Lower Michigan. The firm generates the majority of its revenue from Interest and fees on loans.